David Pau
David Pau publishes mostly in Oncology, Rheumatology and Pulmonary and Respiratory Medicine, on topics such as Rheumatoid Arthritis Research and Therapies, Lung Cancer Treatments and Mutations and Chronic Lymphocytic Leukemia Research.
- World rank
- #6,293,007 of 7,710,434 ranked researchers
- Rank in France
- #268,984 of 324,115
- Works
- 60
- Citations
- 76
- Citations per work
- 1.3
What does David Pau research?
David Pau's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (5%), Computer Science (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3456.6%
- Health Sciences2033.0%
- Medicine2033.0%
- Life Sciences35.2%
- Physical Sciences35.2%
- Computer Science35.2%
- 1Oncology11% of their works
- 2Rheumatology10% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Artificial Intelligence5% of their works
- 5Cancer Research5% of their works
- 6Hematology5% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Lung Cancer Treatments and Mutations
- Chronic Lymphocytic Leukemia Research
- Erythropoietin and Anemia Treatment
- Cancer Genomics and Diagnostics
- Multiple Sclerosis Research Studies
- Systemic Lupus Erythematosus Research
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe David Pau's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Anemia and Chronic Kidney Disease.
- Systemic Lupus Erythematosus
- Mutational Signatures
- Diagnostic Criteria
- Cancer Genomics
- Genomic Aberrations
- Chronic Kidney Disease
- EGFR Mutations
- Targeted Therapy
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- ALK Inhibitors
- Anemia
- Chronic Lymphocytic Leukemia
- Antiphospholipid Syndrome
- Cost-effectiveness Analysis
- Multiple Sclerosis
- Quality of Life
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Autoantibodies152 topics
- Inflammation111 topic
- Rheumatoid Arthritis111 topic
- Targeted Therapy102 topics
- ALK Inhibitors61 topic
- EGFR Mutations61 topic
- Anemia51 topic
- Chronic Kidney Disease51 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Antiphospholipid Syndrome41 topic
- Cancer Genomics41 topic
- Cost-effectiveness Analysis41 topic
- Diagnostic Criteria41 topic
- Multiple Sclerosis41 topic
- Mutational Signatures41 topic
- Quality of Life41 topic
- Systemic Lupus Erythematosus41 topic
Where does David Pau work?
David Pau's main affiliation in the publication record is Roche (France), France.
How many publications and citations does David Pau have?
OpenAlex counts 60 works and 76 citations for David Pau, an h-index of 6, ranking #6,293,007 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Pau. Posts are plain text and can be reported.